NS-863 Low Dose

DRUG2 trials

Sponsors

NS Pharma, Inc.

Conditions

Pulmonary Arterial HypertensionPulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Phase 2

Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Not yet recruitingNCT07441200

NS Pharma, Inc.Pulmonary Arterial Hypertension

Start: 2026-07-01End: 2028-11-01Target: 135Updated: 2026-02-27

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Not yet recruitingNCT07441278

NS Pharma, Inc.Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Start: 2026-07-01End: 2028-12-14Target: 177Updated: 2026-02-27